Fibrosing diseases are chronic pathologies, with a different genesis, characterized by various types of cellular or extracellular infiltrates determining a progressive destruction of the parenchyma, which is replaced by fibrous tissue, causing progressive damage to organ anatomy. Fibrosing diseases are one of the main causes of morbidity and mortality in the Western world.
To date, no effective drugs are available for the treatment of such diseases.
This invention relates to a novel use of 1-piperidin propionic acid as drug for the treatment of fibrosing diseases. The compound acts on SerpinB3, which has been identified as an effective target, it reduces the expression of said molecule and limits fibrotic damage.

TRL

Lead Optimization/Preclinical

Inventors

Patrizia
Pontisso

Alessandra
Biasiolo

Andrea
Cappon

Andrea
Martini

Santina
Quarta

Mariagrazia
Ruvoletto

Cristian
Turato

Gianmarco
Villano

Download the brochure

  • SerpinB3 inhibitor for tumor treatment

    Expression of SerpinB3, a member of serine-protease inhibitor family, is associated with the carcinogenesis process as it determines resistance to apoptosis, induces cell proliferation and greater cell invasiveness. Furthermore, it leads to impaired immune surveillance and reduced chemosensitivity. Recent studies[...]

  • Bicyclic peptides for targeted therapy against cancer

    Since inhibitors based on small molecules and macromolecules are not selective and potent enough, new compounds, including bicyclic peptides, have been developed in recent years. Bicyclic peptides are new generation therapeutic molecules which exhibit properties typical of monoclonal antibodies (high[...]

  • A compound to mitigate the cytokine storm

    The body’s inflammatory response to fight infections and in tissue repair processes is crucial for normal functioning of the body. Yet, if not controlled, it can cause severe injury to the human body, as occurs during cytokine storm, a potentially[...]

Subscribe to newsletter

Follow the activities promoted by UniSMART Foundation